Svelte Medical Launches Drug-Eluting Stent in Europe

New Providence, N.J.-based Svelte Medical Systems has announced the European launch of its SLENDER sirolimus-eluting coronary stent-on-a-wire integrated delivery system to certain accounts specializing in transradial intervention.

The system aims to reduce the catheter size and number of steps necessary to perform percutaneous coronary intervention.

It consolidates the guide wire, delivery balloon stent and drug coating technologies into a single, fixed-wire system, Svelte says.

Svelte also is seeking PMA approval in the U.S. in 2016. — Michael Cipriano